PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

ACG continues production to meet mission-critical pharmaceutical requirements in tackling COVID-19, with employee safety a top priority across its operations

Despite widespread disruption, ACG is continuing production in its factories across the world, and helping to keep supply chains running smoothly to meet mission-critical demands. Being a crucial supplier to the pharmaceutical industry in these difficult times comes with a huge duty of care to employees and associates, and ACG continues to do ‘everything and more’ to protect their safety and wellbeing.

ACG provides dosage capsules and high-barrier blister packaging films for all specifications, plus advanced machinery and technical support for pharmaceutical facilities. All ACG Capsule and ACG Films & Foils factories across the globe are currently running at full capacity, and all orders are being fulfilled.

Of course, employee safety remains a primary concern for ACG at this time, and strict and comprehensive COVID-19 precautionary measures are in place at ACG factories across India, Europe and Brazil to ensure the continued health and safety of all ACG associates.

At plant level, measures comprise daily sanitising of factory premises and property, including common areas, offices and vehicles – plus strict social distancing rules, employee screening, sanitiser dispensers throughout factories, awareness sessions from medical professionals, and full access to personal protective equipment (PPE). Such steps are reviewed and updated continuously to align with expert health advice and policy.

To encourage higher hygiene and safety standards, ACG factory shifts are currently 12 hours, to support social distancing measures and reduce travel between factories and communities. ACG has also arranged medically equipped isolation facilities, and provides worker accommodation at selected sites.

In ‘lockdown’ countries, ACG continues to provide workers with ready-packed vegetables, groceries and sanitation kits to take home to their families. Meanwhile, ACG has arranged special vehicles for safer commuting between home and work, which are sanitised before and after every journey. In India, ACG has also given an additional insurance cover of INR 200,000 (over and above the existing policies), insuring all its employees and their families against medical expenses that may occur this year.

Every ACG plant worldwide has a contingency plan and Standard Operating Procedure for suspected or confirmed cases, and for quarantine.

Additional measures for product transportation

To ensure ACG products and equipment reach customers on time, ACG has been working closely with local government officials to keep manufacturing supply chains as open and efficient as possible. This includes sourcing, securing and distributing everything from gelatin to food colouring and additives, to packaging materials, and more.

ACG Capsules and ACG Films & Foils are classified as ‘Essentials’ by government authorities, so delivery vehicles owned by ACG and its suppliers are ensured safe and smooth transit between key supply-chain locations.

On taking extraordinary safety measures for the ACG workforce, Mr. Sunil Jha, Group CHRO, said,

“People are our first concern – our associates, suppliers, partners, customers, and end-users. All efforts at ACG are dedicated to helping make people, and the world, healthier. It may be our business, but right now it’s also about so much more. We salute the spirit of our employees who are coming to work every day and doing their bit in fighting the COVID-19 virus. ACG stands with them.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026